NCT00005101已完成不适用
Study of Low Bone Mass in Premenopausal or Perimenopausal Women
National Center for Research Resources (NCRR)1 个研究点 分布在 1 个国家开始时间: 1998年2月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 试验地点
- 1
研究概览
简要总结
OBJECTIVES:
I. Determine the possible causes of bone loss in premenopausal or perimenopausal women.
详细描述
PROTOCOL OUTLINE: Patients undergo physical examination and complete history with emphasis on risk factors for osteoporosis and screening for occult secondary causes of osteoporosis through blood serum and 24 hour urine collection.
Patients with more than 6 months since prior bone mineral density measurements or who did not receive measurements at participating center, undergo dual energy x-ray absorptiometry over 30 minutes for bone mineral density measurements.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 16 Years 至 54 Years（Child, Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
The Study of LTBP1 of Postmenopausal Women Osteoporosis Molecular Mechanism of Kidney Yang Deficiency SyndromeKidney Yang Deficiency SyndromeNCT01940380Fujian Academy of Traditional Chinese Medicine25
已完成
不适用
A Pilot Study of Bone Mineral Density in Postmenopausal Women After Treatment for Breast CancerPostmenopausal Bone LossBreast CancerNCT00399321University of Michigan Rogel Cancer Center9
已完成
不适用
Screening of Bone Mineral Density in Women Who Have Received ChemotherapyBone DensityCancerNCT00603551Medical University of South Carolina106
已完成
3 期
Osteoporosis and ovarian function in premenopausal cervical cancer patients who underwent bilateral oophorectomy or concurrent chemo-radiotherapyPremenopausal cervical cancer patients who underwent bilateral oophorectomy or CCRTPre-menopauseBone densityOvarian functionOophorectomyConcurrent ChemoradiotherapyCervical cancerTCTR20201223003one50
进行中（未招募）
不适用
Prevention of Postmenopausal Bone Loss in Osteopenic Women with Alendronate given on a 70 mg Once-every two week Regimen : a 2-year, Double-blind, Placebo-controlled Clinical Trialosteopenia and postmenopausal patientEUCTR2006-005862-38-BECL Mont Godinne150